✦ LIBER ✦

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

✍ Scribed by Janoueix-Lerosey, Isabelle; Lequin, Delphine; Brugières, Laurence; Ribeiro, Agnès; de Pontual, Loïc; Combaret, Valérie; Raynal, Virginie; Puisieux, Alain; Schleiermacher, Gudrun; Pierron, Gaëlle

Book ID: 109897783
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 344 KB
Volume: 455
Category: Article
ISSN: 0028-0836
DOI: 10.1038/nature07398

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Germline and somatic mutations in the ty

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

✍ Schmidt, Laura; Duh, Fuh-Mei; Chen, Fan; Kishida, Takeshi; Glenn, Gladys; Choyke 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 804 KB

Somatic mutations of the ERBB4 kinase do

Somatic mutations of the ERBB4 kinase domain in human cancers

✍ Young Hwa Soung; Jong Woo Lee; Su Young Kim; Young Pil Wang; Keon Hyun Jo; Seok 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

The EGFR family consists of 4 receptor tyrosine kinases, EGFR (ERBB1), ERBB2 (HER2), ERBB3 (HER3) and ERBB4 (HER4). Recent reports revealed that the kinase domains of both EGFR (ERBB1) and ERBB2 gene were somatically mutated in human cancers, raising the possibility that the other ERBB members posse

Novel germline and somatic mutations of

Novel germline and somatic mutations of the MSH2 gene in hereditary non-polyposis colorectal cancer

✍ D-C Ding; R-L Huang; C-H Chen; C-F Chao; T-Y Chu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Loss of RAF kinase inhibitor protein is

Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations

✍ Zebisch, A; Haller, M; Hiden, K; Goebel, T; Hoefler, G; Troppmair, J; Sill, H 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 387 KB

Mutations of activin-receptor-like kinas

Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease

✍ Albert Selva-O’Callaghan; Eva Balada; Silvia Serrano-Acedo; Carmen Pilar Simeon 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 76 KB

METPRC mutations in the ron receptor res

METPRC mutations in the ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential

✍ Tracy A. Williams; Paola Longati; Luisa Pugliese; Philippe Gual; Alberto Bardell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

Ron and Met are structurally related receptor tyrosine kinases that elicit a complex biological response leading to invasive growth. Naturally occurring point mutations activate the Met kinase in papillary renal carcinomas (MET PRC mutations). By site-directed mutagenesis, we generated homologous am